首页|艾沙康唑治疗侵袭性真菌感染的疗效和安全性的Meta分析

艾沙康唑治疗侵袭性真菌感染的疗效和安全性的Meta分析

扫码查看
目的:评价艾沙康唑(ISA)治疗侵袭性真菌感染(IFI)的疗效和安全性,为临床治疗策略的选择提供循证依据。方法:检索Embase、PubMed、Web of Science、the Cochrane Library、维普数据库、中国知网、万方数据库和中国生物医学文献服务系统等,检索时限均为建库至 2023 年 5 月,获取ISA治疗IFI的随机对照试验(RCT)、队列研究和病例对照研究(观察组患者使用ISA单药治疗,对照组患者使用伏立康唑或两性霉素B单药治疗)。对纳入的文献进行质量评价、资料提取,应用RevMan 5。4。1 软件进行Meta分析。结果:共纳入 3 项RCT、3 项队列研究和 1 项病例对照研究,包括 914 例患者。Meta分析结果表明,观察组与对照组患者总有效率(RR=1。00,95%CI=0。84~1。17,P=0。96)、全因死亡率(RR=0。95,95%CI=0。76~1。18,P=0。62)的差异均无统计学意义。安全性方面,观察组患者的总体不良反应发生率低于对照组(RR=0。76,95%CI= 0。58~0。99,P= 0。05);其中视觉异常(RR=0。47,95%CI=0。34~0。67,P<0。000 1)、肝功能损伤(RR=0。56,95%CI=0。38~0。83,P=0。004)的发生率明显低于对照组,差异有统计学意义;但两组患者神经系统不良反应发生率的差异无统计学意义(RR=1。04,95%CI=0。83~1。31,P=0。71)。结论:ISA治疗IFI的疗效与伏立康唑相近,整体安全性优于伏立康唑,尤其是肝功能损伤、视觉异常的发生率低于伏立康唑,但临床应用过程中仍需要关注其神经系统不良反应。
Efficacy and Safety of Isavuconazole in the Treatment of Invasive Fungal Infection:Meta-Analysis
OBJECTIVE:To evaluate the efficacy and safety of isavuconazole(ISA)in the treatment of invasive fungal infection(IFI),so as to provide evidence-based basis for the selection of clinical treatment strategies.METHODS:Embase,PubMed,Web of Science,the Cochrane Library,VIP,CNKI,Wanfang Data and SinoMed were retrieved to collect the randomized controlled trial(RCT),cohort studies and case-control studies of ISA in the treatment of IFI(the observation group was treated with ISA alone,while the control group received voriconazole or amphotericin B alone)up to May 2023.Quality evaluation and data extraction were performed for the included literature,and Meta-analysis was performed by using RevMan 5.4.1 software.RESULTS:A total of 3 RCT,3 cohort studies and 1 case-control studies were enrolled,including 914 patients.Meta-analysis showed that there were no significant differences in the total effective rate(RR=1.00,95%CI=0.84-1.17,P=0.96)and all-cause mortality(RR=0.95,95%CI=0.76-1.18,P=0.62)between the observation group and control group.In terms of safety,the overall incidence of adverse drug reactions in the observation group was lower than that in control group(RR=0.76,95%CI=0.58-0.99,P=0.05).The incidences of visual abnormality(RR=0.47,95%CI=0.34-0.67,P<0.000 1)and liver function injury(RR=0.56,95%CI=0.38-0.83,P=0.004)in the observation group were significantly lower than those in the control group,the difference was statistically significant.However,there was no statistically significant difference in the incidence of neurological adverse reactions between two groups(RR=1.04,95%CI=0.83-1.31,P=0.71).CONCLUSIONS:The efficacy of ISA in the treatment of IFI is similar to that of voriconazole,and the overall safety is better than voriconazole,especially the incidences of liver function injury and visual abnormality are lower than voriconazole.However,it is still necessary to pay attention to the adverse drug reactions of the nervous system during clinical application.

Invasive fungal infectionIsavuconazoleEfficacySafetyMeta-analysis

张坤、邓燕、欧阳冰、刘丽、姜力宁、蔡永青、刘耀

展开 >

陆军特色医学中心药剂科,重庆 400042

侵袭性真菌感染 艾沙康唑 疗效 安全性 Meta分析

重庆市临床药学重点专科建设项目(第一批)重庆市技术创新与应用发展专项重庆市中青年医学高端人才项目(2021)

渝卫办发[2020]68号CSTC2021jscxgksb-N0013

2024

中国医院用药评价与分析
中国医药生物技术协会,中国药房杂志社

中国医院用药评价与分析

CSTPCD
影响因子:1.142
ISSN:1672-2124
年,卷(期):2024.24(3)
  • 22